Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 70 citing articles:

Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options
Wolfgang Löscher, Heidrun Potschka, Sanjay M. Sisodiya, et al.
Pharmacological Reviews (2020) Vol. 72, Iss. 3, pp. 606-638
Open Access | Times Cited: 621
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond
Wolfgang Löscher, Pavel Klein
CNS Drugs (2021) Vol. 35, Iss. 9, pp. 935-963
Open Access | Times Cited: 217
Oxidative Stress and Neurodegeneration in Animal Models of Seizures and Epilepsy
Krzysztof Łukawski, Stanisław J. Czuczwar
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1049-1049
Open Access | Times Cited: 49
New epilepsy therapies in development
Pavel Klein, Rafal M. Kaminski, Matthias J. Koepp, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 9, pp. 682-708
Closed Access | Times Cited: 34
Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy
Wolfgang Löscher
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 86
Animal Models of Drug-Resistant Epilepsy as Tools for Deciphering the Cellular and Molecular Mechanisms of Pharmacoresistance and Discovering More Effective Treatments
Wolfgang Löscher, H. Steve White
Cells (2023) Vol. 12, Iss. 9, pp. 1233-1233
Open Access | Times Cited: 38
The ups and downs of alkyl‐carbamates in epilepsy therapy: How does cenobamate differ?
Wolfgang Löscher, Graeme J. Sills, H. Steve White
Epilepsia (2021) Vol. 62, Iss. 3, pp. 596-614
Open Access | Times Cited: 56
Alzheimer’s Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation
Leanne M Lehmann, Alexandria Lo, Kevin M. Knox, et al.
Neurochemical Research (2021) Vol. 46, Iss. 8, pp. 1895-1912
Open Access | Times Cited: 43
Increased Dentate Gyrus Excitability in the Intrahippocampal Kainic Acid Mouse Model for Temporal Lobe Epilepsy
Marijke Vergaelen, Simona Manzella, Kristl Vonck, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 660-660
Open Access | Times Cited: 7
Anticonvulsive properties of soticlestat, a novel cholesterol 24‐hydroxylase inhibitor
Toshiya Nishi, Cameron S. Metcalf, Shinji Fujimoto, et al.
Epilepsia (2022) Vol. 63, Iss. 6, pp. 1580-1590
Open Access | Times Cited: 26
TRPV1 channel in the pathophysiology of epilepsy and its potential as a molecular target for the development of new antiseizure drug candidates
Katarzyna Socała, Marcin Jakubiec, Michał Abram, et al.
Progress in Neurobiology (2024) Vol. 240, pp. 102634-102634
Open Access | Times Cited: 5
Understanding mechanisms of drug resistance in epilepsy and strategies for overcoming it
Krzysztof Łukawski, Stanisław J. Czuczwar
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 9, pp. 1075-1090
Closed Access | Times Cited: 29
Molecular Mechanisms in the Genesis of Seizures and Epilepsy Associated With Viral Infection
Wolfgang Löscher, Charles L. Howe
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 21
Development of Antiepileptic Drugs throughout History: From Serendipity to Artificial Intelligence
María Gabriela Corrales-Hernández, Sebastián Kurt Villarroel-Hagemann, Isabella Mendoza-Rodelo, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1632-1632
Open Access | Times Cited: 13
Evaluation of antiseizure drug efficacy and tolerability in the rat lamotrigine‐resistant amygdala kindling model
Cameron S. Metcalf, Jennifer Huff, Kyle Thomson, et al.
Epilepsia Open (2019) Vol. 4, Iss. 3, pp. 452-463
Open Access | Times Cited: 28
Antiseizure medication discovery: Recent and future paradigm shifts
Alan Talevi
Epilepsia Open (2022) Vol. 7, Iss. S1
Open Access | Times Cited: 16
Challenges and directions in epilepsy diagnostics and therapeutics: Proceedings of the 17th Epilepsy Therapies and Diagnostics Development conference
Samuel W. Terman, Laura Kirkpatrick, Wesley T. Kerr, et al.
Epilepsia (2023) Vol. 65, Iss. 4, pp. 846-860
Open Access | Times Cited: 8
Stereoselective Analysis of the Antiseizure Activity of Fenfluramine and Norfenfluramine in Mice: Is l-Norfenfluramine a Better Follow-Up Compound to Racemic-Fenfluramine?
Natalia Erenburg, Emilio Perucca, Jeff Bechard, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2522-2522
Open Access | Times Cited: 3
Innovative drug discovery strategies in epilepsy: integrating next-generation syndrome-specific mouse models to address pharmacoresistance and epileptogenesis
Melissa Barker‐Haliski, Nicole A. Hawkins
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 9, pp. 1099-1113
Closed Access | Times Cited: 3
Antiseizure drug efficacy and tolerability in established and novel drug discovery seizure models in outbred vs inbred mice
Zachery Koneval, Kevin M. Knox, Ali Memon, et al.
Epilepsia (2020) Vol. 61, Iss. 9, pp. 2022-2034
Open Access | Times Cited: 22
Spontaneous recurrent seizures in an intra-amygdala kainate microinjection model of temporal lobe epilepsy are differentially sensitive to antiseizure drugs
Peter J. West, Kyle Thomson, P. R. Billingsley, et al.
Experimental Neurology (2021) Vol. 349, pp. 113954-113954
Open Access | Times Cited: 20
Pronounced antiseizure activity of the subtype‐selective GABAA positive allosteric modulator darigabat in a mouse model of drug‐resistant focal epilepsy
Rachel Gurrell, Philip Iredale, Alexis Evrard, et al.
CNS Neuroscience & Therapeutics (2022) Vol. 28, Iss. 11, pp. 1875-1882
Open Access | Times Cited: 13
Cannabidiol reveals a disruptive strategy for 21st century epilepsy drug discovery
Aarón del Pozo, Melissa Barker‐Haliski
Experimental Neurology (2022) Vol. 360, pp. 114288-114288
Open Access | Times Cited: 13
The feast and famine: Epilepsy treatment and treatment gaps in early 21st century
Wolfgang Löscher, Pavel Klein
Neuropharmacology (2020) Vol. 170, pp. 108055-108055
Closed Access | Times Cited: 19
Discovery of the First Vitamin K Analogue as a Potential Treatment of Pharmacoresistant Seizures
Xiaoyang Li, Richard A. Himes, Lyndsey C. Prosser, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 11, pp. 5865-5878
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top